ENDS, cigarettes, and respiratory illness
Mukerjee R, et al. ENDS, cigarettes, and respiratory illness: Longitudinal associations among US youth. Am J Prev Med. 2023 Dec 9:S0749-3797(23)00503-2. doi: 10.1016/j.amepre.2023.12.005. Epub ahead of print. PMID: 38081374. “7.4% of respondents were diagnosed with bronchitis, pneumonia, or chronic cough at follow-up. In the multivariable model, exclusive cigarette use (IRR = 1.85; 95% CI 1.29-2.65), exclusive ENDS use (IRR = 1.49; 95% CI 1.06-2.08), and dual use (IRR = 2.70, 95% CI 1.61-3.50) were associated with a higher risk of diagnosed bronchitis, pneumonia, or chronic cough, compared to never/non-current use.
https://pubmed.ncbi.nlm.nih.gov/38081374/
These results suggest that ENDS and cigarettes, used exclusively or jointly, increased the risk of diagnosed bronchitis, pneumonia, or chronic cough among U.S. youth. However, dual use was associated with the highest risk. Targeted policies aimed at continuing to reduce cigarette smoking and ENDS use among youth, especially among those with dual use, are needed.”
Stephen Hamann
